BMO Capital Markets Increases Encompass Health (NYSE:EHC) Price Target to $88.00

Encompass Health (NYSE:EHC) had its target price boosted by investment analysts at BMO Capital Markets from $85.00 to $88.00 in a note issued to investors on Tuesday, Stock Target Advisor reports. The brokerage currently has an “outperform” rating on the stock. BMO Capital Markets’ price objective would suggest a potential upside of 13.58% from the company’s previous close.

Other equities analysts have also recently issued reports about the company. ValuEngine cut Encompass Health from a “buy” rating to a “hold” rating in a research note on Wednesday, October 30th. UBS Group lifted their price target on Encompass Health from $80.00 to $87.00 and gave the stock a “buy” rating in a research note on Friday. Finally, Deutsche Bank initiated coverage on Encompass Health in a research note on Tuesday, September 17th. They issued a “hold” rating and a $70.00 price target on the stock. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $78.00.

NYSE:EHC traded up $0.80 during mid-day trading on Tuesday, reaching $77.48. The stock had a trading volume of 539,425 shares, compared to its average volume of 578,670. The firm has a 50 day moving average price of $70.36 and a two-hundred day moving average price of $65.96. The stock has a market capitalization of $7.56 billion, a P/E ratio of 21.34, a P/E/G ratio of 2.17 and a beta of 0.82. Encompass Health has a one year low of $56.74 and a one year high of $76.77. The company has a debt-to-equity ratio of 1.94, a quick ratio of 0.97 and a current ratio of 0.97.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Monday, October 28th. The company reported $0.93 EPS for the quarter, topping the Zacks’ consensus estimate of $0.89 by $0.04. The business had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.16 billion. Encompass Health had a return on equity of 23.89% and a net margin of 7.07%. Research analysts forecast that Encompass Health will post 3.86 earnings per share for the current year.

About Encompass Health

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Further Reading: Cash Flow

Stock Target Advisor

Analyst Recommendations for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with's FREE daily email newsletter.